chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was sitting in the waiting area after his vaccination for the standard 10-15 minute observance period, when he became light-headed and fainted while seated in a standard height chair. 911 was immediately called and the patient was aroused after about 10-15 seconds. He remained in the recovery position until EMS arrived and escorted him outside of the building to their ambulance to check his vitals and check on him. He did report to me before EMS arrived that he has fainted several times in the past after giving blood. On his vaccine administration consent form, he did select "no" when asked if he had ever had a serious reaction after receiving a vaccination in the past.
First vaccine 9/10/2021. Patient developed burning of tongue and lips. Occasional numbness of left arm and left leg. Second dose 10/01/2021. Patient developed Severe back pain. Thoracic and Lumbar with Radiculopathy of bilateral arms and legs. Left axillary lymphadenopathy and breast pain and swelling. As of Today, this symptoms are still present.
Muscular pain in both upper arms well after initial vaccine reaction had subsided, normal movement of arm up and/or back and rapid movements in other axes cause intense muscle pain followed by severe minutes of pain fading to dull ache. The pain issue has only worsened since it's onset. The pain in each arm is proportionate to the initial vaccine reaction, meaning the arm that got the second dose experiences more sever pain than the one that got the first. The pain in both is preventing normal activities and affecting quality of life.
Low grade fever, muscle soreness, resolved, tinnitus 2 days unresolved.
sick to her stomach; difficulty breathing; HOT; nauseous; everything hurt (muscle pain); headache; chills; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous) and MYALGIA (everything hurt (muscle pain)) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy NOS. Concomitant products included ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever). At the time of the report, ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
very tired; body pain; sore arm; Chills; This is a Spontaneous report based on the information received by Pfizer (Manufacturer Control No: 21K-163-3805390-00). A contactable 69-year-old female consumer reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9267) via intramuscular route of administration on 26Feb2021 (at 69-year-old), as dose 2, single for COVID-19 immunization and adalimumab (Humira) for crohn's disease via subcutaneous route on an unknown date in 2017 at a dose of 40 mg, 2x/week. The patient's medical history included tobacco user from 1960 to 1981, alcohol use from 1970 to an unknown date alcohol use a glass of wine occasionally (Started 1970) and lyme disease from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medications included iron taken for supplementation therapy, start and stop date were not reported; vitamin D3 taken for supplementation therapy, start and stop date were not reported; cyamopsis tetragonoloba gum (Benefiber fiber supplement) taken for supplementation therapy, start and stop date were not reported; acetylsalicylic acid (Aspirin (E.C.)) taken for cardiac disorder, start and stop date were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 05Feb2021 (at 69-year-old), at single dose for COVID-19 immunization. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. On 26Feb2021, the patient experienced very tired, body pain, sore arm and chills. On 27 Feb 2021 the patient resolved.  No follow-up attempts were possible. No further information was expected.
No adverse effect; multiple patients were vaccinated with improperly stored VARIVAX; This spontaneous report was received from a medical assistant referring to a patient of an unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 27-MAR-2019, the patient was vaccinated with 1 dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose and route of administration were not reported) (lot # R022117 and expiry date 02-AUG-2020) for prophylaxis (product storage error). Other suspect therapy included sterile diluent (strength, dose and route of administration, lot# and expiry date were not reported). There was no adverse effect reported. There was a previous temperature excursion and the time frame and temperature was unknown. No product quality complaint (PQC) was reported.  This is one of several reports received from the same reporter.
Red Rash on R side of Nose. R shoulder clavicle, neck area red rash, increased temp slight pruritis at R should and R fase. Resolved after 24 hrs.
At 2:15PM child reported to health room on day of vaccination.  Clinic held that AM. Chief c/o dizziness and legs tingling.  Oral temp. was 99 degrees F.  Child said felt dizzy in class, put head down and fell asleep.  Awoke with legs tingling.  Call to Mom at 3:00 PM, tingling much better. 3:15 to MD.  Next day no tingling in legs and no dizziness reported.
1 week after injection.  Injection site became itchy, red and had a raised lump at site. Area was about the size of a  golf ball.  There is still a small bump at site 2 weeks later
From correspondence received on 11/14/01, it was reported that a 26 year old patient received a Fluzone SV '01 -'02 vaccination on 11/14/01 at 1:30 pm. By 2 pm, he had developed urticaria. Antihbistimine relieved. Patient has many allergies, one allergy to horses.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Apr2021 as dose 1, single (Lot number: EW0171), in left arm and on 11May2021 as dose 2, single (Lot number: EW0183) at the age of 29 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 09Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Negative; (Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Follow-up attempts are completed. No further information is expected.
vasovagal syncope, all of pt symptoms were resolved within 15 min after laying down
Patient filled out paperwork and did not show previous vaccine dose (assuming Johnson and Johnson) and when we processed claim it showed pt did have previous covid vaccine reported as a single dose vaccine.
Fever (101.4), joint pain/body aches, red/sore throat, chest tightness/cough, hoarseness.
pt recv vax & devel an allergic rxn characterized by facial redness, puffiness, & itching;pt recovered w/o tx;
This spontaneous report as received from nurse refers to unspecified patients of unknown age and gender. The patient's pertinent medical history and concomitant medications were not reported. No previous drug reactions or allergies were reported. On an unknown date the patients were vaccinated with improperly stored doses of ROTATEQ (dosing details were not reported) (lot # L028645 expiry date: 25-MAY-2017) and (lot # L039141 expiry date: 16-AUG-2017). No adverse effects were reported. There was no product quality complaint involved. This is one of two reports received from the same reporter. Additional information has been requested.
A nurse reported that an 18 month old male received his 4th dose of Diphtheria and Tetanus Toxoids Adsorbed, as well as his 1st dose of Hib-Titer and MMR II on 9/25/91. The child has developed neurological problems. As of 9/13/00, the reporter had no information on type or description of neurological problems, or when they became evident.
On 4/3/2003 c/o chest hurting and heavy feeling.  On 3/15/03 was very stressed due to home situation.  Layed down and symptoms went away.  No other problems since that time.
Upper left arm became very red and warm. Patient given allegra 60mg and waited 30 minutes longer. After 30 minutes upper arm was slightly pink and slightly warm. Patient felt well and left for home with instructions to follow up in ER or with her physician for any other S/S
Pt informed us that their left arm has been sore for over a month. There is no redness or swelling at site of administration. But arm is soRE.
Pt recvd vax 4NOV92 & a few hrs following vax devel severe back pain, stiffness in the spine w/difficulty in bending & muscle pain in the spinal area; pain was in the spinal cord;
I woke up on May 1st, with a rash under the breast to the back. On Tuesday, I spiked a temperature, and the medication that was given was double. The shingles was very painful. When my temperature did not dropped I was admitted to the hospital where I was monitored and treated until my release on May 10th. My body could not handle oral medication, I needed infusions. I was put in isolation with infection until my body was able to fight it.   I am still fighting the after effects of the infection as well as the fatigue.
lump in arm and neck; knee went out; lump in arm and neck; rash; arthritic pain; fever; chills; Myocardial infarction; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Myocardial infarction) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced LIMB MASS (lump in arm and neck), ARTHROPATHY (knee went out), NECK MASS (lump in arm and neck), RASH (rash), ARTHRALGIA (arthritic pain), PYREXIA (fever) and CHILLS (chills). In 2021, the patient experienced MYOCARDIAL INFARCTION (Myocardial infarction) (seriousness criterion medically significant). At the time of the report, MYOCARDIAL INFARCTION (Myocardial infarction), LIMB MASS (lump in arm and neck), ARTHROPATHY (knee went out), NECK MASS (lump in arm and neck), RASH (rash), ARTHRALGIA (arthritic pain), PYREXIA (fever) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: myocardial infarction (abnormal) myocardial infarction.   The physician scheduled echo on 17-Sep-2021. No concomitant medications was provided. No treatment medications was provided. Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-027089 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Aug-2021: Follow-up received on 20-AUG-2021.event and lab data were added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Vaccination was on Wednesday, March 17, 2021 at 3 PM.   Symptoms began 8 days later, and Emergency Room admission 3days later on Sunday, March 28, 2021, for Blood Clots in legs and lungs,(critical in Pulmonary Artery).  Blood thinner started immediately was Zarelto, and continues daily.  Pain, nausea, shortness of breath, and fatigue were the symptoms.  The patient was admitted to hospital for 5 days and sent home to recuperate.  3 days later, on Sunday she was back into the emergency department with intestinal bleeding that had gone on for 2 days.  She was admitted again and had a colonoscopy.  Bleeding stopped and she went home after 3 more days.  She is currently getting home health care.
1. Within 7 minutes of vaccine, developed left side (arm and leg) numbness and weakness 2. Within 7 minutes of vaccine developed extreme dizziness and lightheadedness 3. Within 1 day of vaccine developed tinnitus - loud tones in both ears 4. Within 1 day of vaccine developed vaginal bleeding lasting for 7 days 5. Within 2 days of vaccine, unrelenting dizziness and feeling as if head on a boat and closing in (incapacitating dizziness and rocking in the head, loss of balance, lasting approximately 10 weeks and then lingering with frequent dizzy spells and nausea for several months) 6. Heart racing / palpitations - terrifying spells of high heart beat rate during the night 7. Nightmares, sweats, sleeplessness accompanied by dizziness and loss of balance
pt recvd vax;was fussy p/vax;started crying,approx 6 hrs p/vax;cried x 3 hrs;T 100.4;next am 99.8 & felt better;local area was red blotchy & hard;
Vertigo; Migraine; Chills; This is a spontaneous report from a non-contactable consumer, the patient.  A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 12:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin d nos (VITAMIN D) and echinacea (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Mar2021 at 11:00, the patient experienced vertigo, migraine and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vertigo, migraine and chills was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
male patient, 4 month old at the time of administration received a dose of Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) for prophylaxis.   On 16-JAN-2023, the patient received Kinrix. On 16-JAN-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: male patient, 4 month old at the time of administration received a dose of Kinrix). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 19-MAY-2023 No lot number or expiration date were available. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.  The 4-month-old patient at the time of administration received a dose of Kinrix, which led to inappropriate age at vaccine administration.
It hurts; Burns; I had the two shots two years ago now have shingles/ suspected vaccination failiure; Have shingles right now; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In January 2022, between 1 and 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced suspected vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced pain and burning sensation. On an unknown date, the outcome of the suspected vaccination failure, pain and burning sensation were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the suspected vaccination failure, shingles, pain and burning sensation to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received 2 shots of Shingles vaccine 2 years ago from reporting date and had shingles right now. Less than 2 years after vaccination, the patient also experienced hurts and burns. Consent to follow up was not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding laboratory test confirming shingles was unknown at the time of reporting.
LF deltoid region, swelling - red, hyperemia, tender to touch, size 6.5 x 7". No discharge - sharp margin.
Fatigue/headache and left sided lymph node swelling on her neck since getting her second covid shot in the left arm 3 days ago.  Pfizer
AFTER RECEIVING THE FLU SHOT THE PATIENT PRESENTED WITH REDNESS IN THE AREA OF INJECTION AND PAIN. THE PATIENT RECEIVED BENADRYL AND SOLUMEDROL.
Fainted in apartment parking lot, on morning of April 3; transported to ER,, via ambulance.  Hospital stay for several days, moved to Rehab, sent back to ER with a cough, trouble breathing, and swallowing. Diagnosed with pneumonia. Went into coma on 4/18. Passed away on 4/22/2021.
A little after 4pm on 8/18/21 patient got his J&J covid vaccine. He was nervous about the vaccine and did not like needles. After the vaccine he seemed calm and chatted with me for a minute before going and having a seat in the waiting area. A few minutes after he sat down the patient fainted - falling towards another patient who was waiting after his vaccine. The other patient said it looked like he was having a seizure. Staff member called 911 right away. I ran out and saw the patient still falling from his chair. He bumped his head as he fainted and me and the other patient helped him to the ground. He came to within seconds and kept apologizing. I told him not to apologize and got him some water. He kept saying he was fine. EMS arrived and took some vitals. They said the patient could go to the hospital if he wanted and he said he didn't want to go. They were getting his paperwork together when he fainted a second time. They took him by ambulance to Medical Center.
The patient got the vaccine on 10/08/22. By 10/09/22 the patient arm began to swell. She had a localized reaction that was red and warm to touch. It seemed to be below injection site.
01/28/21 - bodyaches 01/29/21 - headache and bodyaches 01/30/21 - reticular rash on bilateral upper extremities, chest, abdomen, upper and lower back; burning, itching to rash area; bodyaches, headache; redness with induration around injection area (left deltoid) - He took Tylenol, Ibuprofen, and Benadryl
No additional adverse experiences reported.; administration of an expired dose of MMR II; This spontaneous report was received from an office manager, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided.  On 10-NOV-2021, the patient was vaccinated with an expired single dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) as prophylaxis (exact dose, route of administration, vaccination scheme frequency, and anatomical location were not reported; lot number 035356 was an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II); lot number 035356 does not match any Company product as confirmed by Lot Verification team; expiration date was reported as 05-NOV-2021) (expired product administered). There was no previous temperature excursion reported. No adverse experiences were reported.
Mild headache; joint pain; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 55-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on unknown dates. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 13:00, the patient experienced mild headache, joint pain and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events mild headache, joint pain and tiredness was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Noticed a red lesion around the injection site that didn't show up until 12 days after I got my first shot. It's slightly itchy and warm to the touch. No pain. I  reported it  because I saw that others had the same reaction and it scared me until I found out that it was a known side effect.  * I received a shingrix vaccine on November 23rd 2020 but it wasn't within a month of the Covid vaccine so I didn't mark it on this form. I wanted to give the info just in case it might be helpful.
Patient brought in by EMS due to 2 episodes of emesis, not eating for past week with on and off vomiting episodes, and altered mental status. Possible urinary tract infection, treated with antibiotics